SAN DIEGO, Nov. 3, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:... [read full story]
|
RELATED
|
|
SAN DIEGO, Nov. 3, 2009 (GLOBE NEWSWIRE) -- News) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced the initiation of a Phase Ib clinical trial, by holding the Investigator's Meeting,...
Breathing Problems, Infections, Investing & Markets, Medicines & Remedies, Scientific Discoveries, Health Care, Finance, Banking & Insurance, Pharmaceuticals, Ambulatory Health Care, Biopharmaceuticals, Asthma Medication, Patients, Medical Research, Asthma, Bronchitis, Investing, Osaka Securities, Fukushima Prefecture, Iwaki, Japan
